Halozyme Therapeutics Inc (HALO)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | |
| DSO | days | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
Based on the data provided, it seems that the days of sales outstanding (DSO) for Halozyme Therapeutics Inc is not available for the years ranging from December 31, 2020, to December 31, 2024. This lack of specific DSO figures may indicate that the company either does not disclose or calculate this particular metric.
Days of sales outstanding (DSO) is a measure of how quickly a company collects its accounts receivable from customers. A lower DSO is generally preferred as it suggests faster collection of receivables and efficient management of cash flow. Conversely, a higher DSO may indicate potential issues with collections and liquidity.
Without specific DSO data for Halozyme Therapeutics Inc, it is challenging to assess the effectiveness of their accounts receivable management and the impact on their overall financial health. Therefore, further information or analysis is needed to fully evaluate the company's performance in this area.
Peer comparison
Dec 31, 2024